The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression

Pain

Volumn 75, Issue 2-3, 1998, Pages 313-319

  Benedetti, Fabrizio ^a   Amanzio, Martina ^a   Baldi, Sergio ^a   Casadio, Caterina ^a   Cavallo, Antonio ^a   Mancuso, Maurizio ^a   Ruffini, Enrico ^a   Oliaro, Alberto ^a   Maggi, Giuliano ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Opioid; Pain perception; Placebo analgesia; Placebo respiratory depression

Indexed keywords

BUPRENORPHINE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY FUNCTION;

ANALGESIA; ANALGESICS, OPIOID; BUPRENORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; RESPIRATORY INSUFFICIENCY; RETREATMENT;

EID: 0031924010     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00010-4     Document Type: Article

References (45)

1. Austin K.L., Stapleton J.V., Mather L.E. Multiple intramuscular injection: a major source of variability in analgesic responses to meperidine. Pain. 8:1980;47-62.
2. Beecher H.K. The powerful placebo. J. Am. Med. Assoc. 159:1955;1602-1606.
3. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain. 64:1996;535-543.
4. Benedetti F., Amanzio M. The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Prog. Neurobiol. 52:1997;109-125.
5. Benedetti F., Amanzio M., Maggi G. Potentiation of placebo analgesia by proglumide. Lancet. 346:1995;1231.
6. Benedetti F., Amanzio M., Casadio C., Oliaro A., Maggi G. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain. 71:1997;135-140.
7. Cowan, A. and Lewis, J.W., Buprenorphine: Combatting Drug Abuse with a Unique Opioid, Wiley-Liss, New York, 1995.
8. Evans, F.J., The placebo control of pain: a paradigm for investigating non-specific effects in psychotherapy. In: J.P. Brady, J. Mendels, W.R. Reiger and M.T. Orne (Eds.), Psychiatry: Areas of Promise and Advancement, Plenum Press, New York, 1997, pp. 249-271.
9. Evans, F.J., Expectancy, therapeutic instructions, and the placebo response. In: L. White, B. Tursky and G.E. Schwartz (Eds.), Placebo: Theory, Research, and Mechanisms, Guilford Press, New York, 1985, pp. 215-228.
10. Fields H.L. Commentary on 'The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia'. Neurol. Network Commentary. 1:1997;26-29.
11. Fields H.L., Levine J.D. Placebo analgesia - a role for endorphins? Trends Neurosci. 7:1984;271-273.
12. Gleidman L.H., Gantt W.H., Teitelbaum H.A. Some implications of conditional reflex studies for placebo research. Am. J. Psychiatry. 113:1957;1103-1107.
13. Gracely R.H., Dubner R., Wolskee P.J., Deeter W.R. Placebo and naloxone can alter postsurgical pain by separate mechanisms. Nature. 306:1983;264-265.
14. Grevert, P. and Goldstein, A., Placebo analgesia, naloxone, and the role of endogenous opioids. In: L. White, B. Tursky and G.E. Schwartz (Eds.), Placebo: Theory, Research, and Mechanisms, Guilford Press, New York, 1985, pp. 332-350.
15. Grevert P., Albert L.H., Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain. 16:1983;129-143.
16. Herrnstein R.J. Placebo effect in the rat. Science. 138:1962;677-678.
17. Honigfeld, G., Nonspecific factors in treatment: I. Review of placebo reactions and placebo reactors, Dis. Nerv. Syst., 25 (1964a) 145-156.
18. Honigfeld, G., Nonspecific factors in treatment: II. Review of social-psychological factors, Dis. Nerv. Syst., 25 (1964b) 225-239.
19. Lasagna L., Beecher H.K. The optimal dose of morphine. J. Am. Med. Assoc. 156:1954;230-234.
20. Levine J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet. 2:1978;654-657.
21. Levine J.D., Gordon N.C. Influence of the method of drug administration on analgesic response. Nature. 312:1984;755-756.
22. Ling G.S.F., Pasternak G.W. Spinal and supraspinal analgesia in the mouse: the role of subpopulations of opioid binding sites. Brain Res. 271:1983;152-156.
23. Ling G.S.F., Spiegel K., Lockhart S.H., Pasternak G.W. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J. Pharmacol. Exp. Ther. 232:1985;149-155.
24. Ling G.S.F., Spiegel K., Nishimura S.L., Pasternak G.W. Dissociation of morphine's analgesic and respiratory depressant actions. Eur. J. Pharmacol. 86:1983;487-488.
25. Lyerly S.B., Ross S., Krugman A.D., Clyde D.J. Drugs and placebos: the effects of instructions upon performance and mood under amphetamine sulphate and chloral hydrate. J. Abnorm. Soc. Psychol. 68:1964;321-327.
26. McGlashan T.H., Evans F.J., Orne M.T. The nature of hypnotic analgesia and placebo response to experimental pain. Psychosom. Med. 31:1969;227-246.
27. Moskowitz A., Goodman R.R. Autoradiographic analysis of mu-1 and mu-2- and delta-opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor deficient) mice. Brain Res. 360:1985;108-116.
28. Park, G.R. and Gempeler, F., Sedation and Analgesia, Saunders, London, 1993.
29. Pasternak G.W. Multiple morphine and enkephalin receptors and the relief of pain. J. Am. Med. Assoc. 259:1988;1362-1367.
30. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
31. Pasternak, G.W., Childer, S.R. and Snyder, S.H., Naloxazone, a long-acting opiate antagonist: effects in intact animals and on opiate receptors binding in vitro, J. Pharmacol. Exp. Ther., 214 (1980a) 455-462.
32. Pasternak, G.W., Childer, S.R. and Snyder, S.H., Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors, Science, 208 (1980b) 514-516.
33. Schachter S., Singer J.E. Cognitive, social and physiological determinants of emotional states. Psychol. Rev. 69:1962;379-399.
34. Siegel, S., Drug-anticipatory responses in animals. In: L. White, B. Tursky and G.E. Schwartz (Eds.), Placebo: Theory, Research and Mechanisms, Guilford Press, New York, 1985, pp. 288-305.
35. Smith T.C., Stephen G.W., Zeiger L., Wollman H. Effects of premedicant drugs on respiration and gas exchange in man. Anesthesiology. 28:1967;883-890.
36. Tamsen A., Hartvig P., Dahlstrom B., Lindstrom B., Holmdahl M.H. Patient controlled analgesic therapy in the early postoperative period. Acta Anaesth. Scand. 23:1979;462-470.
37. Voudouris N.J., Peck C.L., Coleman G. Conditioned response models of placebo phenomena: further support. Pain. 38:1989;109-116.
38. Voudouris N.J., Peck C.L., Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain. 43:1990;121-128.
39. Wall P.D. The placebo effect: an unpopular topic. Pain. 51:1992;1-3.
40. Wall, P.D., Pain and the placebo response. In: Ciba Foundation Symposium 174, Experimental and Theoretical Studies of Consciousness, Wiley, New York, 1993, pp. 187-216.
41. Wickramasekera I. A conditioned response model of the placebo effect: predictions from the model. Biofeedback Self-Reg. 5:1980;5-18.
42. Wickramasekera, I., A conditioned response model of the placebo effect: predictions from the model. In: L. White, B. Tursky and G.E. Schwartz (Eds.), Placebo: Theory, Research, and Mechanisms, Guilford Press, New York, 1985, pp. 255-287.
43. White, L., Tursky, B. and Schwartz, G.E., Placebo: Theory, Research, and Mechanisms, Guilford Press, New York, 1985.
44. Wolf S. Effects of suggestion and conditioning on the action of chemical agents in human subjects: the pharmacology of placebos. J. Clin. Invest. 29:1950;100-109.
45. Zhang A.Z., Pasternak G.W. Opiates and enkephalins: a common binding site mediates their analgesic actions in rats. Life Sci. 29:1981;843-857.